mTOR抑制剂在癌症治疗中的应用演示幻灯片.pptVIP

mTOR抑制剂在癌症治疗中的应用演示幻灯片.ppt

  1. 1、本文档共26页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
The model shown was developed with a combination of preclinical and clinical data. The slide shows that daily dosing with either 5 mg or 10 mg is better at maintaining inhibition of pS6K compared with the weekly schedule. mTOR Inhibitors (mTOR抑制剂) in Cancer Therapy RuiRong Yuan, MD, PhD Oncology, Novartis VA Medical Center, UMDNJ mTOR Mammalian Target of Rapamycin (哺乳动物雷帕霉素靶蛋白) A central regulator of cell growth and metabolism (控制细胞的生长和代谢) mTOR is an intracellular serine-threonine kinase (丝氨酸-苏氨酸激酶) mTOR is downstream of growth factor/nutrient and PI3k/AKT signalling pathway (信号通路中的下游分子) mTOR is a central regulator of protein synthesis Activated by mutations in cancer Nutrients Growth Factors IGF, EGF, VEGF etc PI3K glucose, amino acids, etc Mutations in cancer AKT S6k eif-4e Protein Synthesis Growth Proliferation Bioenergetics Angiogenesis mTOR (哺乳动物雷帕霉素靶蛋白) mTOR Pathway Activation Protein Synthesis Growth Factors Cell Growth Proliferation Bioenergetics Angiogenesis mTOR PI3K EGF IGF VEGF AKT RAS ER ABL AMPK RAS TSC1 TSC2 PTEN LKB1 Regulators of mTOR activity mTOR activating mTOR deactivating Mutations of PI3K, Akt, Ras, GFRs, TSC1/2, PTEN..) may result in inappropriate activation of the pathway and loss of control of functions normally regulated by mTOR Activation of mTOR can result in loss of cell growth control and enhanced cell metabolism in cancer cells (无限制的癌细胞生长和扩散) mTOR Activation ↑Increased synthesis of multiple proteins, including: Hypoxia-Inducible Factors (HIFs, 低氧诱导 因子): ↑expression of angiogenic growth factors (eg, VEGF/ PDGF) (RCC) Cyclin D1: promotes progression through the cell cycle (MCL) Proteins necessary to transport nutrients (amino acids and glucose) into the cell mTOR-Linked Pathway Activation in Selected Cancers Breast NET Colorectal Lung Renal Cell p-Akt, 42% PTEN, 15%–41% HER2, 30%–36% PI3-K, 18%–26% TSC1/TSC2 IGF-1/IGF-1R VHL Ras, 50% p-Akt, 46% PTEN, 35% PI3-K, 20%–32% EGFR, 70% EGFR, 32%–60

文档评论(0)

yuzongxu123 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档